You are viewing: Australia Cold Plasma Market analysis
Part of: Cold Plasma Market (Global)

The Australia Cold Plasma Market was valued at $6.48 Million in 2024 and projected to reach to $9.82 Million by 2029, representing a compound annual growth rate of 8.7%. Australia's cold plasma market is positioned for sustained growth through 2029, supported by increasing healthcare investments and growing clinical evidence for cold plasma applications in wound healing, sterilization, and dermatological treatments.

Australia Cold Plasma Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Australia Cold Plasma Market Trends and Insights

  • Valued at USD 6.48 million in 2024, Australia's market is projected to expand to USD 9.82 million by 2029, reflecting an 8.7% compound annual growth rate.
  • This growth trajectory demonstrates Australia's increasing adoption of cold plasma technologies in clinical and therapeutic applications across the healthcare industry. The Australian cold plasma market benefits from advanced healthcare infrastructure, rising investment in medical innovation, and growing awareness of non-thermal plasma applications.
  • Australia's healthcare sector continues to integrate cold plasma solutions for wound healing, sterilization, and dermatological treatments.
  • Between 2024 and 2029, Australia is expected to see accelerated market penetration driven by regulatory support and clinical validation of cold plasma therapies. Australia's position within the Asia Pacific region positions it as a key market for cold plasma adoption.
  • The country's emphasis on research and development, coupled with strong healthcare spending, supports the expansion of cold plasma technologies throughout the forecast period..

Key Market Statistics

  • CAGR (2024-2029) 8.7% CAGR
  • Market Size, 2024 ~USD 6.48 Million
  • Forecast, 2029 ~USD 9.82 Million
  • Country Australia

Australia Cold Plasma Market Overview

Market Valuation :

Australia's cold plasma market was valued at USD 6.48 million in 2024 and is projected to reach USD 9.82 million by 2029, representing a robust 8.7% CAGR over the forecast period.

Regional Growth Position :

Australia's 8.7% CAGR demonstrates steady market expansion within the Asia Pacific healthcare sector, positioning the country as a growing hub for cold plasma technology adoption and clinical implementation.

Clinical Application Expansion :

Australian healthcare providers are increasingly integrating cold plasma technologies across therapeutic and clinical applications, driven by rising awareness of non-thermal treatment benefits and regulatory support.

Healthcare Innovation Adoption :

Australia's advanced healthcare infrastructure and strong emphasis on medical innovation are accelerating the adoption of cold plasma solutions in hospitals, clinics, and research institutions across the country.

Australia Cold Plasma Market Dynamics

  • The country's robust healthcare system and emphasis on adopting cutting-edge medical technologies create favorable conditions for market expansion. Key drivers include rising healthcare expenditure, growing awareness among medical professionals, and expanding applications in therapeutic settings.
  • As Australian hospitals and clinics continue to modernize their treatment capabilities, cold plasma technology adoption is expected to accelerate, with particular momentum in specialized medical centers and research-driven healthcare facilities..

Market Ecosystem

logo-mobile

COLD PLASMA MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
company logo
Enables controlled plasma processing for high-precision manufacturing, improving process uniformity and supporting advanced semiconductor and electronics production. Develops plasma generators and plasma processing technologies used in semiconductor, electronics, and thin-film manufacturing applications, including etching, deposition, and surface treatment under controlled plasma conditions.
company logo
Enables precise, automated plasma treatment for surface modification, cleaning, and adhesion improvement, supporting consistent processing and reduced use of chemical pretreatment. Provides plasma-based surface treatment solutions used for cleaning, activation, and surface modification of plastics, metals, glass, and electronic components | These systems help improve coating and adhesive bonding while supporting automated manufacturing processes.
company logo
Improves surface energy, adhesion, and wettability while enabling inline, chemical-free surface treatment with high process consistency. Develops atmospheric-pressure plasma systems, including Openair-Plasma, for surface cleaning, activation, functionalization, and coating preparation across automotive, electronics, medical, and polymer industries.
company logo
Develops high-performance cleanroom garments, protective materials, and barrier fabrics used in pharmaceutical, semiconductor, and microelectronics facilities. Provides atmospheric-pressure plasma systems for surface activation, cleaning, and functionalization of plastics, composites, metals, and other materials | Its plasma solutions can be integrated into automated production lines for continuous treatment.
company logo
Provides access to specialized plasma and scientific instrumentation technologies supporting advanced research, surface treatment, and industrial processing applications. Through its scientific-instrumentation subsidiaries, supports specialized technologies used in research, materials analysis, plasma processing, and advanced industrial applications, depending on the subsidiary and product portfolio.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • Australia's cold plasma market is valued at USD 6.48 million in 2024 and is forecast to reach USD 9.82 million by 2029.
    • Australia demonstrates an 8.7% CAGR, reflecting strong healthcare sector adoption of cold plasma technologies.
    • Australia's advanced medical infrastructure and R&D investment drive clinical validation and market expansion.
    • Australia's market growth is supported by increasing applications in wound care, sterilization, and dermatological treatments.

    Cold Plasma Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment MEDICAL INDUSTRY (Industry)
    Forecast Period 2024-2029
    Growth Rate CAGR of 11% from 2024 to 2029
    Largest Segment ATMOSPHERIC COLD PLASMA (Regime)
    Market Size Base Year (Billions) ~USD 2.14 (2024)
    Revenue Forecast (Billions) ~USD 3.6 (2029)
    Segments Covered Industry, Application, Regime

    Australia Cold Plasma Market Report Segmentation

    3 segment dimensions are covered across the global market.

    By Industry

    • Cosmetic Industry
    • Electronics & Semiconductors Industry
    • Food & Agriculture Industry
    • Medical Industry
    • Other Industries
    • Polymer & Plastic Industry
    • Textile Industry

    By Application

    • Aesthetic Procedures
    • Coating & Thin-Film Deposition
    • Other Applications
    • Printing
    • Surface Cleaning & Decontamination
    • Surface Etching
    • Surface Treatment & Activation
    • Surgical
    • Wound Healing

    By Regime

    • Atmospheric Cold Plasma
    • Low-Pressure Cold Plasma

    AUSTRALIA: COLD PLASMA MARKET, BY INDUSTRY, 2022–2029

    Segment20222023202420252026202720282029CAGR (%)
    COSMETIC INDUSTRY0.380.390.410.430.460.490.530.587.4
    ELECTRONICS & SEMICONDUCTORS INDUSTRY3.753.924.174.534.95.355.96.549.4
    FOOD & AGRICULTURE INDUSTRY1.191.231.291.391.491.611.761.938.3
    MEDICAL INDUSTRY1.361.451.581.761.942.172.452.7711.8
    OTHER INDUSTRIES0.20.20.210.220.230.240.260.286.1
    POLYMER & PLASTIC INDUSTRY5.916.126.486.987.58.148.929.818.7
    TEXTILE INDUSTRY4.084.24.424.735.055.445.926.487.9
    TOTAL16.8717.518.5720.0321.5623.4525.7428.398.9

    Target Audience

    • Medical Device Manufacturers : Manufacturers need Australia-specific market data to develop localized go-to-market strategies, understand clinical adoption requirements, and identify partnership opportunities with Australian healthcare providers and distributors.
    • Healthcare Facility Operators : Hospital administrators and clinic operators require market insights to evaluate cold plasma technology investments, benchmark against regional adoption trends, and plan capital expenditure for therapeutic equipment upgrades.
    • Investment & Private Equity Firms : Investors need detailed Australia market analysis to assess growth potential, identify acquisition targets in the cold plasma sector, and evaluate return on investment opportunities within the Asia Pacific healthcare market.
    • Healthcare Consultants & Advisors : Consulting firms require Australia-specific market data to advise healthcare clients on technology adoption strategies, competitive positioning, and market expansion opportunities in the cold plasma therapeutic space.
    • Regulatory & Clinical Research Organizations : Research institutions and regulatory bodies need comprehensive market data to understand clinical adoption patterns, identify research gaps, and inform policy decisions regarding cold plasma technology integration in Australian healthcare.

    Reasons to Buy this Report

    • Australia-Specific Market Sizing : Access precise valuation data for Australia's cold plasma market with verified 2024 baseline (USD 6.48M) and 2029 forecasts (USD 9.82M), enabling accurate business planning and investment decisions tailored to the Australian market.
    • Competitive Landscape Intelligence : Understand Australia's unique competitive dynamics, local market players, and regional healthcare adoption patterns to identify market entry opportunities and competitive positioning strategies specific to the Australian healthcare sector.
    • Regulatory & Healthcare Infrastructure Insights : Gain detailed knowledge of Australia's healthcare regulations, TGA approval pathways, hospital procurement processes, and clinical adoption barriers to accelerate market entry and product commercialization strategies.
    • Growth Driver Analysis : Identify Australia-specific growth catalysts including healthcare spending trends, clinical adoption rates, therapeutic application expansion, and regional investment patterns driving the 8.7% CAGR through 2029.
    • Strategic Investment Guidance : Make informed investment and expansion decisions with comprehensive Australia market data, including market size projections, growth trajectories, and opportunity assessment for healthcare providers, device manufacturers, and investors.

    Frequently asked questions

    What is the current size of Australia's cold plasma market?

    Australia's cold plasma market was valued at USD 6.48 million in 2024 and is expected to grow to USD 9.82 million by 2029.

    What is the projected growth rate for cold plasma in Australia?

    Australia's cold plasma market is projected to grow at a compound annual growth rate (CAGR) of 8.7% from 2024 to 2029.

    What are the primary applications of cold plasma in Australia?

    In Australia, cold plasma is primarily used for wound healing, medical device sterilization, and dermatological treatments within the healthcare sector.

    What factors are driving cold plasma market growth in Australia?

    Australia's market growth is driven by advanced healthcare infrastructure, increased R&D investment, regulatory support, and clinical validation of cold plasma therapies.

    How does Australia's cold plasma market compare to the Asia Pacific region?

    Australia represents a significant market within Asia Pacific, leveraging its strong healthcare system and innovation capabilities to drive cold plasma adoption.

    RESEARCH METHODOLOGY

    This study involved four major activities in estimating the size of the cold plasma market. Exhaustive secondary research was conducted to gather information on the market, the peer market, and the parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across value chains through primary research. The bottom-up approach was employed to estimate the overall market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and sub-segments.

    Secondary Research

    The secondary research process involved the extensive use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, Companies House documents, investor presentations, and SEC filings. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the cold plasma technologies market. It was also used to obtain important information about key players, market classification and segmentation according to industry trends down to the bottom level, and key developments from market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing & sales directors, technology & innovation directors, and other key executives from various companies and organizations operating in the cold plasma market. The primary sources on the demand side included industry experts, purchasing & sales managers, doctors, and personnel from research organizations. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends and key market dynamics.

    Cold Plasma Marke 
 Size, and Share

    Note 1: C-level executives include CEOs, CFOs, COOs, and VPs.
    Note 2: Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
    Note 3: Companies are classified into tiers based on their total revenue. As of 2025, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.
    Source: MarketsandMarkets Analysis

    The research methodology used to estimate the size of the cold plasma market is as follows.

    Market sizing was conducted from a global perspective.

    Country-level Analysis: The size of the cold plasma market was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of products in the overall cold plasma market was obtained from secondary data and validated by primary participants to arrive at the total cold plasma market. Primary participants further validated the numbers.

    Geographic Market Assessment (Region & Country): The geographic assessment was done using the following approaches:

    Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends

    Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)

    At each point, the assumptions and approaches were validated through industry experts contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall cold plasma technologies market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.

    The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Cold Plasma Marke Top Down and Bottom Up Approach

    Data Triangulation

    After determining the overall size of the global cold plasma market using the aforementioned methodology, the market was segmented into several subsegments. The data triangulation and market breakdown procedures were employed, where applicable, to complete the overall market engineering process and derive the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macroindicators and regional trends from both demand- and supply-side participants.

    Market Definition

    Plasma is the fourth state of matter. Cold plasma is a partially ionized gas comprising ions, electrons, ultraviolet photons, and reactive neutrals such as radicals and ground- and excited-state molecules. It is an innovative and convenient alternative to traditional technologies used across a wide range of industries, including textiles, electronics & semiconductors, polymers & plastics, medical, cosmetic and food & agriculture.

    Key Stakeholders

    • Cold plasma manufacturers and distributors
    • Government and research organizations
    • Cold plasma application industries
    • Plasma technology component suppliers
    • Medical device manufacturing companies
    • Healthcare organizations
    • Government associations
    • Market research and consulting firms
    • Venture capitalists and investors
    • Corporate entities

    Report Objectives

    • To describe, analyze, and forecast the cold plasma market by industry, application, regime, and region
    • To describe and forecast the cold plasma market in key regions—North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
    • To provide detailed information regarding drivers, restraints, opportunities, and challenges influencing market growth
    • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for market players
    • To profile key players and comprehensively analyze their market shares and core competencies in the cold plasma market
    • To analyze competitive developments such as partnerships, collaborations, agreements & acquisitions, product launches, expansions, and R&D activities in the cold plasma market
    • To analyze the impact of AI/Gen AI on the cold plasma market in terms of its capabilities, potential, use cases, and future

    Available customizations:

    With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

    Geographic Analysis

    • Further breakdown of the Rest of Asia Pacific cold plasma market into Indonesia, Philippines, Vietnam, Hong Kong, and other countries
    • Further breakdown of the Rest of Europe cold plasma market into Belgium, Russia, the Netherlands, Switzerland, and other countries.
    • Further breakdown of the Rest of Latin America cold plasma market into Argentina, Peru, and other countries
    • Further breakdown of Rest of Middle East & Africa cold plasma market into Israel, Iran, Iraq, Jordan, Yemen, and other countries.

     

    Get the Full Cold Plasma Market Report

    Full forecast, segment splits, and company analysis for all Cold Plasma Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status